Guo Zhu Zheng - Concepedia

Concepedia

Author

Guo Zhu Zheng

Also Known As

G Z Zheng, G. Z. ZHENG, G. Z. Zheng, Guo Z. Zheng, Guo Zheng, Guo Zhu Zheng, Zheng, Guo, Zheng, Guo Zhu

34

Publications

1.1K

Citations

18

H-Index

27

Concepts

All Affiliations

Abbott Fund Abbott (United Kingdom)Neurobehavioral Research Laboratory and Clinic Abbott (United States)Institute for Biomedicine

GZ

About

Guo Zhu Zheng is an author at Abbott Fund specializing in pharmacology, medicine, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	578
2	Biochemistry	9	9	557
3	Engineering	3	3	263
4	Natural Sciences	3	3	218
5	Health Sciences	2	2	184

Guo Zhu Zheng

×

17

Publications

1.1K

Citations

17

H-Index

	Year	Citations
Novel Transient Receptor Potential Vanilloid 1 Receptor Antagonists for the Treatment of Pain: Structure−Activity Relationships for Ureas with Quinoline, Isoquinoline, Quinazoline, Phthalazine, Quinoxaline, and Cinnoline Moieties Arthur Gomtsyan, Erol K. Bayburt, Robert G. Schmidt, Journal of Medicinal Chemistry Pain MedicineImmunologyReceptor AntagonistsNeuropathic PainMolecular Pain	2005	163
Regiocontrolled Hydrosilation of .alpha.,.beta.-Unsaturated Carbonyl Compounds Catalyzed by Hydridotetrakis(triphenylphosphine)rhodium(I) Guo Zhu Zheng, T. H. Chan Organometallics EngineeringDonut IconT. H. ChanciteAltmetric Attention ScoreOrganic Chemistry	1995	125
Catalytic reactions of samarium (II) iodide E. J. Corey, Guo Zhu Zheng Tetrahedron Letters Inorganic ChemistryEngineeringOrganometallic CatalysisCatalysisChemistry	1997	112
Discovery of Selective Estrogen Receptor Covalent Antagonists for the Treatment of ERαWT and ERαMUT Breast Cancer Xiaoling Puyang, Craig Furman, Guo Zhu Zheng, Cancer Discovery	2018	109
Fatty acid amide hydrolase inhibitors display broad selectivity and inhibit multiple carboxylesterases as off-targets Di Zhang, Anita Saraf, Teodozyi Kolasa, Neuropharmacology Drug TargetBiochemistryMedicineNatural SciencesInhibit Multiple Carboxylesterases	2007	99
Structure−Activity Relationship of Triazafluorenone Derivatives as Potent and Selective mGluR1 Antagonists Guo Zhu Zheng, Pramila Bhatia, Jerome F. Daanen, Journal of Medicinal Chemistry Molecular PainPharmacotherapyTriazafluorenone DerivativesMolecular PharmacologyMedicinal Chemistry	2005	71
Blockade of mGluR1 receptor results in analgesia and disruption of motor and cognitive performances: effects of A‐841720, a novel non‐competitive mGluR1 receptor antagonist Odile F. El-Kouhen, Sonya G. Lehto, Jia Bao Pan, British Journal of Pharmacology	2006	50
Tetrahydropyridine-4-carboxamides as novel, potent transient receptor potential vanilloid 1 (TRPV1) antagonists Brian S. Brown, Ryan G. Keddy, Guo Zhu Zheng, Bioorganic & Medicinal Chemistry BiochemistryFunctional SelectivityMedicineReceptor (Biochemistry)Pharmacology	2008	48
5-(3-Bromophenyl)-7-(6-morpholin-4-ylpyridin-3-yl)pyrido[2,3-d]pyrimidin-4-ylamine: structure–activity relationships of 7-substituted heteroaryl analogs as non-nucleoside adenosine kinase inhibitors Mark A. Matulenko, Chih‐Hung Lee, Meiqun Jiang, Bioorganic & Medicinal Chemistry Molecular PharmacologyMedicinal ChemistryBiochemistryMedicineNatural Sciences	2005	48
Adenosine kinase inhibitors: polar 7-Substitutent of pyridopyrimidine derivatives improving their locomotor selectivity Guo Zhu Zheng, Yue Mao, Chih‐Hung Lee, Bioorganic & Medicinal Chemistry Letters Molecular PharmacologyPyridopyrimidine DerivativesMolecular PhysiologyBiochemistryFunctional Selectivity	2003	43

Page 1